Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Shockwave Medical; TriReme Medical; Surmodics; Abbott; Boston Scientific Corporation; Concept Medical</li><li>Advisory Board - Abbott Vascular; Boston Scientific Corporation; Medtronic; BD; Cordis Corporation, a Johnson & Johnson company</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abiomed; Terumo Medical Corporation; Inari Medical; Penumbra; Shockwave Medical</li><li>Equity/Stock(s)/Options - Encompass Vascular; Advanced Nanotherapies</li></ul>